
Accelerate Diagnostics Inc
NASDAQ:AXDX

Intrinsic Value
The intrinsic value of one
AXDX
stock under the Base Case scenario is
3.69
USD.
Compared to the current market price of 0.04 USD,
Accelerate Diagnostics Inc
is
Undervalued by 99%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Fundamental Analysis


Revenue & Expenses Breakdown
Accelerate Diagnostics Inc
Balance Sheet Decomposition
Accelerate Diagnostics Inc
Current Assets | 22.2m |
Cash & Short-Term Investments | 16.3m |
Receivables | 2m |
Other Current Assets | 3.9m |
Non-Current Assets | 6.3m |
PP&E | 5.8m |
Other Non-Current Assets | 500k |
Free Cash Flow Analysis
Accelerate Diagnostics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Accelerate Diagnostics Inc
Revenue
|
11.7m
USD
|
Cost of Revenue
|
-9m
USD
|
Gross Profit
|
2.7m
USD
|
Operating Expenses
|
-38m
USD
|
Operating Income
|
-35.3m
USD
|
Other Expenses
|
-14.7m
USD
|
Net Income
|
-50m
USD
|
AXDX Profitability Score
Profitability Due Diligence
Accelerate Diagnostics Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Score
Accelerate Diagnostics Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
AXDX Solvency Score
Solvency Due Diligence
Accelerate Diagnostics Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.

Score
Accelerate Diagnostics Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AXDX Price Targets Summary
Accelerate Diagnostics Inc
Dividends
Current shareholder yield for AXDX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?